|
If she is referring to the Oncotype, it's possible that ALL Her2 tumors will test high risk. Johns Hopkins Ask an Expert describes the Oncotype DX as a test for node-neg stage 1 tumors that are NOT Her2+. I bet that no Her2+ tumor has ever tested other than high risk, though I don't have the data to prove it.
__________________
MJO
IDC, Stage I, Grade 2
Oncotype DX Score 32
Her2++ E+P+, Node Neg.
Lumpectomy 11/04/05 Clear Margins
3 Dose dense AC (Couldn't tolerate 4)
4 Dose dense Taxol & Herc. (Tolerated well)
36 weeks Herceptin (Could not complete one year due to decrease in MUGA score)
2 years of Arimidex, then three years of Femara
Finished Femara May 2011
|